PARP1 and cancer: From this standpoint, it is a potential strategy to induce DNA damage and apoptosis by ICMT inhibition, either as a single agent or in combination with DNA damage–inducing agents such as PARP inhibitors or irradiation to achieve broader efficacy against resistant cancer cells (Fig 8C).